Therapeutic Options for the SARS-CoV-2 Virus: Is There a Key in Herbal Medicine?

被引:2
|
作者
Sharma, Nitin [1 ]
Kulkarni, Giriraj T. [2 ]
Bhatt, Anant Narayan [3 ]
Satija, Saurabh [4 ,5 ]
Singh, Lubhan [6 ]
Sharma, Anjana [7 ]
Dua, Kamal [4 ]
Karwasra, Ritu [8 ]
Khan, Asim Ali [8 ]
Ahmad, Nadeem [9 ]
Raza, Khalid [10 ]
机构
[1] ISF Coll Pharm, Dept Pharmaceut, Moga, Punjab, India
[2] Gokaraju Rangaraju Coll Pharm, Hyderabad, Telangana, India
[3] Def Res & Dev Org, Dept Nucl Med, Inst Nucl Med & Allied Sci, Delhi, India
[4] Univ Technol Sydney, Grad Sch Hlth, Discipline Pharm, Ultimo, NSW, Australia
[5] Lovely Profess Univ, Sch Pharmaceut Sci, Phagwara, Punjab, India
[6] Swami Vivekanand Subharti Univ, KharvelSubharti Coll Pharm, Dept Pharmacol, Meerut, Uttar Pradesh, India
[7] Meerut Inst Engn & Technol, Dept Pharmaceut Technol, Meerut, UP, India
[8] Govt India, Cent Council Res Unani Med CCRUM, Minist AYUSH, New Delhi, India
[9] Jamia Millia Islamia, Dept Biosci, New Delhi 110025, India
[10] Jamia Millia Islamia, Dept Comp Sci, New Delhi 110025, India
关键词
SARS-CoV-2; herbal medicine; natural product; coronavirus; pneumonia; GLYCYRRHIZIC ACID; BETULINIC ACID; CORONAVIRUS SARS-COV-2; ENTEROVIRUS; 71; IN-VITRO; DERIVATIVES; PHARMACOLOGY; INHIBITORS; HESPERIDIN; LYCORINE;
D O I
10.1177/1934578X221126303
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
SARS-CoV-2 has been responsible for over 500 million cumulative cases all over the world since December 2019 and has marked the third introduction of a highly pathogenic virus after SARS-CoV and MERS-CoV. This virus is in a winning situation because scientists are still racing to explore effective therapeutics, vaccines, and event treatment regimens. In view of progress in current disease management, until now none of the preventive/treatment measures can be considered entirely effective to treat SARS-CoV-2 infection. Therefore, it is required to look up substitute ways for the management of this disease. In this context, herbal medicines could be a good choice. This article emphasizes the antiviral potential of some herbal constituents which further can be a drug of choice in SARS-CoV-2 treatment. This article may be a ready reference for discovering natural lead compounds and targets in SARS-CoV-2 associated works.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Therapeutic nanobodies against SARS-CoV-2
    Güttler T.
    Dobbelstein M.
    Görlich D.
    BIOspektrum, 2022, 28 (1) : 39 - 42
  • [22] Integrins as Therapeutic Targets for SARS-CoV-2
    Gressett, Timothy E.
    Nader, Danielle
    Robles, Juan Pablo
    Buranda, Tione
    Kerrigan, Steven W.
    Bix, Gregory
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [23] Herbal Therapeutics as Potential Prophylaxis for SARS-CoV-2 Infection
    Singhal, Shipra
    Kumar, Abhishek
    Katiyar, Deepti
    Patil, Vaishali M.
    NATURAL PRODUCTS JOURNAL, 2023, 13 (04):
  • [24] Herbal Medicines as Potential Inhibitors of SARS-CoV-2 Infection
    Rostami, Soodabeh
    Gharibi, Shima
    Yaghoobi, Hajar
    Nokhodian, Zary
    Shoaei, Parisa
    Bahrami, Armina Alagheband
    Ahangarzadeh, Shahrzad
    Alibakhshi, Abbas
    CURRENT PHARMACEUTICAL DESIGN, 2022, 28 (29) : 2375 - 2386
  • [25] Molecular Architecture of the SARS-CoV-2 Virus
    Yao, Hangping
    Song, Yutong
    Chen, Yong
    Wu, Nanping
    Xu, Jialu
    Sun, Chujie
    Zhang, Jiaxing
    Weng, Tianhao
    Zhang, Zheyuan
    Wu, Zhigang
    Cheng, Linfang
    Shi, Danrong
    Lu, Xiangyun
    Lei, Jianlin
    Crispin, Max
    Shi, Yigong
    Li, Lanjuan
    Li, Sai
    CELL, 2020, 183 (03) : 730 - +
  • [26] SARS-CoV-2 and Influenza Virus Coinfection
    Kaptan, Figen
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2020, 25 (04): : 457 - 463
  • [27] Cross Section of SARS-CoV-2 Virus
    不详
    ISSUES IN SCIENCE AND TECHNOLOGY, 2021, 37 (02) : 96 - 96
  • [28] SARS-CoV-2 virus: Vaccines in development
    Huang, Qingrui
    Yan, Jinghua
    FUNDAMENTAL RESEARCH, 2021, 1 (02): : 131 - 138
  • [29] Influenza Virus and SARS-CoV-2 Vaccines
    Sandor, Adam M.
    Sturdivant, Michael S.
    Ting, Jenny P. Y.
    JOURNAL OF IMMUNOLOGY, 2021, 206 (11): : 2509 - 2520
  • [30] Novel Corona Virus (SARS-CoV-2)
    Honemann, Mario
    Lubbert, Christoph
    Liebert, Uwe G.
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2020, 58 (03): : 213 - 214